DOCIVYX J Code: J9172

Drug & Product Overview

HCPCS Descriptor Injection, docetaxel (docivyx), 1 mg

HCPCS Added Date January 1, 2024

Manufacturer Avyxa Pharma

Route of Administration Intravenous

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Injection, Solution

About DOCIVYX

Docivyx is a medication aligned to the HCPCS J Code: J9172 for billing, pricing, and reimbursement purposes in the United States. It is an Antibiotic drug administered via the intravenous route and manufactured by Avyxa Pharma.

According to CMS Drug Use Information: This medication is used to treat cancer (such as breast, lung, prostate, stomach, and head/neck cancer). Docetaxel is a member of a family of drugs called taxanes. This drug works by slowing cell growth.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Package	Manufacturer	HCPCS Units	WAC	AWP
83831-0101-02	20 MG / 2 ML Docivyx Intravenous Injection 20 MG/2ML - 1 VIAL, GLASS in 1 CARTON (83831-101-02) / 2 mL in 1 VIAL, GLASS	Avyxa Pharma, LLC	20	$1,081.70 $54.085 / unit	$1,298.04 $64.902 / unit
83831-0102-08	80 MG / 8 ML Docivyx Intravenous Injection 80 MG/8ML - 1 VIAL, GLASS in 1 CARTON (83831-102-08) / 8 mL in 1 VIAL, GLASS	Avyxa Pharma, LLC	80	$4,326.79 $54.085 / unit	$5,192.15 $64.902 / unit
83831-0103-16	160 MG / 16 ML Docivyx Intravenous Injection 160 MG/16ML - 1 VIAL, GLASS in 1 CARTON (83831-103-16) / 16 mL in 1 VIAL, GLASS	Avyxa Pharma, LLC	160	$8,653.58 $54.085 / unit	$10,384.30 $64.902 / unit

Effective 4/1/26 (WAC & AWP)

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

DOCIVYX Pricing & Reimbursement

J9172 Private Payer Reimbursement

$51.71 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

NDC Package

HCPCS Units

Markup / Markdown

%

Common:

Estimates only. Payer reimbursement varies by contract, site of care, and sequestration.

Estimated Reimbursement

Docetaxel 505(b)(2) Information:

HCPCS Code	Manufacturer	Active Ingredient	HCPCS Description
J9171	Generic Code (Multiple Manufacturers)	Docetaxel	Injection, docetaxel, 1 mg
J9172	Avyxa Pharma	Docetaxel	Injection, docetaxel (docivyx), 1 mg
J9174	Zydus Pharmaceuticals	Docetaxel	Injection, docetaxel (beizray), 1 mg

DOCIVYX Claims Performance

Claims from Jan 2026 – Aug 2026

Claim Denial Rate 12.76%

Avg. Days to File 7.9days

Avg. Days to Pay 26.4days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J9172 claims analytics on FocalPoint →

DOCIVYX CPT Administration Codes

CPT Code	Description
96413	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)

Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

DOCIVYX Medically Unlikely Edits (MUE)

The most billing units of J9172 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.

Practitioner Office & Hospital Outpatient

300 units / day

= 300 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

DOCIVYX Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Breast Cancer Gastric Adenocarcinoma Head and Neck Cancer Metastatic CRPC Non-small Cell Lung Cancer

Drug Class

Microtubule Inhibition [PE]Microtubule Inhibitor [EPC]

Frequently Asked Questions

Is there an available Docivyx billing and coding guide?

Billing and coding information for DOCIVYX can be found through Avyxa Pharma. Visit Here →

Are there any available Docivyx patient assistance programs?

DOCIVYX patient assistance information can be found through Avyxa Pharma. Visit Here →

Where can I find Docivyx prescribing information?

DOCIVYX prescribing information is available at the link below. Visit Here →

Where can I find Docivyx side effect information?

Information regarding DOCIVYX side effects can be found at MedlinePlus

Does billing DOCIVYX require JZ/JW wastage modifiers?

CMS does not include DOCIVYX (J9172) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9172. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.